Global HEOR Director: Value & Access Strategy

Ipsen Biopharmaceuticals Inc.; Paris; On-site; EUR 120,000 - 180,000; Full time

Job summary

Ipsen Biopharm Ltd seeks Director Global HEOR to lead value evidence generation across Oncology, Rare Disease, and Neuroscience, collaborating with Market Access, Medical Affairs, Clinical Development, and Regulatory teams to support payer value propositions worldwide.

The initial focus is Rare Disease with expansion across Ipsen's portfolio; you will shape integrated evidence generation plans, implement RWE/PRO strategies, and contribute to pricing and market access strategies.

Qualifications

• Postgraduate degree in health economics or related quantitative discipline.
• 8+ years' HEOR experience in pharma, consultancy or academia, in an international setting.
• Experience working on international HTA submissions.
• Strong scientific analysis, interpretative and writing skills.
• Knowledge of international health care systems.
• HEOR expertise across Oncology, Rare Disease and/or Neuroscience including evidence synthesis, cost-effectiveness and budget impact modeling, RWE methodologies for outcomes research and PROs.
• Knowledge of trial design and understanding of key clinical, PRO and resource utilization endpoints.

Responsibilities

• Lead launch readiness and post-launch updates and development of core HEOR/Access deliverables including systematic and targeted literature reviews, burden of illness studies, unmet medical needs, clinical and patient-relevant outcomes, clinical guidelines, comparative effectiveness including evidence synthesis (including indirect treatment comparisons and network meta-analyses), Cost-Effectiveness Analysis models, Budget Impact Analysis models, Global Value Dossiers, Payer/Product Value Propositions, Objection Handlers for Ipsen products.
• Lead EU HTA Regulation JCA planning and execution as applicable aligned with product assignments.
• Support Payer value evidence communication through presentation of abstract/posters of key work at clinical and HEOR conferences and manuscript publications.
• Contribute to development, updates and execution of cross-functional Integrated Evidence Generation Plans for Ipsen products working with cross-functional teams ensuring strategic alignment of planned and ongoing HEOR activities.
• Lead and inform RWE, health outcomes / Patient-reported outcomes strategy and execution supporting development of a compelling Value proposition for payers and other key stakeholders.
• Lead and inform pipeline target product and value profile and clinical development plans including payer-relevant endpoint in clinical trials.
• Support development of pricing policy and market access of the company products.
• Work collaboratively with local affiliates and global cross-functional team including but not limited to Global Medical Aairs, Global Regulatory Affairs, Clinical, Biostatistics, Public Affairs, Marketing etc.
• Stay abreast of the evolving payer/HTA landscape in terms of policies, guidelines and trends leveraging up-to-date knowledge in strategic HEOR planning.
• Provide training to local country colleagues on value evidence for local adaptation and use.

Skills

HEOR expertise

Evidence synthesis

Cost-effectiveness

Budget impact

RWE methods

PROs knowledge

Trial design

HTA submissions

Education

Postgraduate degree in health economics

Job description

Ipsen Biopharm Ltd seeks Director Global HEOR to lead value evidence generation across Oncology, Rare Disease, and Neuroscience, collaborating with Market Access, Medical Affairs, Clinical Development, and Regulatory teams to support payer value propositions worldwide.

The initial focus is Rare Disease with expansion across Ipsen's portfolio; you will shape integrated evidence generation plans, implement RWE/PRO strategies, and contribute to pricing and market access strategies.